Sort
48,018 grants matching “immunotherapy”
Loss of NF1 drives hormone dependent mammary carcinogenesis in a rat model with intact immune system
$519,825Deeann Wallis-Schultz · University Of Alabama At Birmingham · R01 · FY2024 · CA
HLA-DR Targeted Synthetic High Affinity Ligands
$519,709Gerald L Denardo · University Of California At Davis · P01 · FY2006 · CA
Resource for Nonhuman Primate Immune Reagents
$519,644Francois J Villinger · Emory University · R24 · FY2010 · RR
Targeting tumor-associated macrophages for triple-negative breast cancer treatment
$519,592Mingye Feng · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$519,464Jinming Gao · Ut Southwestern Medical Center · U01 · FY2019 · CA
Project 1- Elucidating oncogenic KRAS in PDAC cell signaling, resistance and immunity
$519,415Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2024 · CA
Alternative Pathways for CD4+ T Cell Epitope Generation from Influenza Antigens
$519,340Laurence Crane Eisenlohr · Thomas Jefferson University · R56 · FY2013 · AI
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
$519,263Richard J Price · University Of Virginia · R01 · FY2017 · CA
Impact of Foreign Bodies on Infection Susceptibility, Disease and Mucosal Remodeling of the Urinary Tract
$519,244Scott J Hultgren · Washington University · R01 · FY2024 · DK
Nanoparticles to reprogram innate immune cells and disrupt the metastatic niche
$519,210Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2024 · EB
A novel signaling mechanism for LRP5
$519,210Dianqing Wu · Yale University · R01 · FY2024 · CA
A Comprehensive 5K Plus Glycan Microarray
$519,198Jian Zhang · Z Biotech, Llc · R44 · FY2022 · GM
Enhancing neoadjuvant chemotherpay responses with targeted T cells
$519,027Lawrence G Lum · Wayne State University · R01 · FY2010 · CA
Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
$518,979David Nemazee · Scripps Research Institute, The · R01 · FY2020 · AI
Novel CART Cells for Treating AML
$518,949Xianxin Hua · University Of Pennsylvania · R01 · FY2025 · CA
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
$518,832James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Immunology of Acute and Chronic Viral Hepatitis
$518,784Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Leveraging Novel Randomized Clinical Trials of Vitamin D Supplementation in Patients with Colorectal Cancer: Impact on Survival and Anti-Tumor Immunity
$518,698Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Biology of the Human Platelet Fc(gamma) Receptor
$518,655Alan D Schreiber · University Of Pennsylvania · P01 · FY2007 · HL
Immune Regulation in the Microenvironment of Oropharyngeal Cancer
$518,635Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Structure-based engineering of immune cytokine signaling
$518,623Kenan Christopher Garcia · Stanford University · R01 · FY2024 · AI
Structure-based engineering of immune cytokine signaling
$518,623Kenan Christopher Garcia · Stanford University · R01 · FY2025 · AI
Pro-tumorigenic functions of human DNA polymerases eta and kappa during genome duplication under physiological replication stress conditions
$518,614Kristin A Eckert · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2019 · CA
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles
$518,603Sunil Krishnan · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · DE
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles
$518,603Sunil Krishnan · Mayo Clinic Jacksonville · R01 · FY2020 · DE